[go: up one dir, main page]

WO2012135635A3 - Marqueurs biologiques de cancer de l'ovaire - Google Patents

Marqueurs biologiques de cancer de l'ovaire Download PDF

Info

Publication number
WO2012135635A3
WO2012135635A3 PCT/US2012/031484 US2012031484W WO2012135635A3 WO 2012135635 A3 WO2012135635 A3 WO 2012135635A3 US 2012031484 W US2012031484 W US 2012031484W WO 2012135635 A3 WO2012135635 A3 WO 2012135635A3
Authority
WO
WIPO (PCT)
Prior art keywords
ovarian cancer
cancer biomarkers
biomarkers
absence
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2012/031484
Other languages
English (en)
Other versions
WO2012135635A2 (fr
Inventor
Jian-Bing Fan
Russell GROCOCK
Keira CHEETHAM
Richard Shaw
Jeremy R. CHIEN
Vijayalakshmi Shridhar
Lynn Hartmann
Dirk Evers
John Peden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mayo Foundation for Medical Education and Research
Illumina Inc
Mayo Clinic in Florida
Original Assignee
Mayo Foundation for Medical Education and Research
Illumina Inc
Mayo Clinic in Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Foundation for Medical Education and Research, Illumina Inc, Mayo Clinic in Florida filed Critical Mayo Foundation for Medical Education and Research
Publication of WO2012135635A2 publication Critical patent/WO2012135635A2/fr
Publication of WO2012135635A3 publication Critical patent/WO2012135635A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La présente invention concerne des marqueurs biologiques et des procédés pour les utiliser dans la détermination de la présence ou de l'absence d'un cancer. Dans des modes de réalisation préférés, des marqueurs biologiques et des procédés pour les utiliser permettent de déterminer la présence ou l'absence d'un cancer de l'ovaire, d'un type de cancer de l'ovaire et/ou d'un stade de cancer de l'ovaire dans un échantillon provenant d'un individu.
PCT/US2012/031484 2011-03-30 2012-03-30 Marqueurs biologiques de cancer de l'ovaire Ceased WO2012135635A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161469510P 2011-03-30 2011-03-30
US61/469,510 2011-03-30

Publications (2)

Publication Number Publication Date
WO2012135635A2 WO2012135635A2 (fr) 2012-10-04
WO2012135635A3 true WO2012135635A3 (fr) 2013-03-07

Family

ID=46932377

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/031484 Ceased WO2012135635A2 (fr) 2011-03-30 2012-03-30 Marqueurs biologiques de cancer de l'ovaire

Country Status (1)

Country Link
WO (1) WO2012135635A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101432173B1 (ko) * 2013-01-22 2014-08-22 한국원자력의학원 Ｈｎｒｎｐｕｌ1을 측정하는 제제를 포함하는 방사선 저항성 또는 민감성 진단용 조성물 및 이의 용도
CN106460064A (zh) * 2014-04-08 2017-02-22 新加坡科技研究局 卵巢癌标志物及其用途
CN111635942A (zh) * 2020-06-22 2020-09-08 中国人民解放军空军军医大学 评估女性恶性肿瘤风险的突变基因群、文库及试剂盒
CN114966027A (zh) * 2022-04-30 2022-08-30 重庆大学附属肿瘤医院 一种三个基因表达水平的检测试剂在制备卵巢癌样本干性鉴定试剂中的应用

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DANSONKA-MIESZKOWSKA, A. ET AL.: "A novel germline PALB2 deletion in Polish breast and ovarian cancer patients", BMC MED. GENET., vol. 11, no. 20, 2 February 2010 (2010-02-02) *
JAKUBOWSKA, A. ET AL.: "The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers", BREAST CANCER RES. TREAT., vol. 121, no. 3, June 2010 (2010-06-01), pages 639 - 649, XP019814399 *
MADORE, J. ET AL.: "Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma", J. PATHOL., vol. 220, no. 3, February 2010 (2010-02-01), pages 392 - 400 *
OLIVA, E. ET AL.: "High frequency of beta-catenin mutations in borderline endometrioid tumors of the ovary", J. PATHOL., vol. 208, no. 5, April 2006 (2006-04-01), pages 708 - 713 *
WIEGAND, K. C. ET AL.: "ARID1A mutations in endometriosis-associated ovarian carcinomas", N. ENGL. J. MED., vol. 363, no. 16, 14 October 2010 (2010-10-14), pages 1532 - 1543, XP055098627, DOI: doi:10.1056/NEJMoa1008433 *

Also Published As

Publication number Publication date
WO2012135635A2 (fr) 2012-10-04

Similar Documents

Publication Publication Date Title
MX340453B (es) Biomarcadores para cancer de pulmon.
WO2012021887A3 (fr) Biomarqueurs pour la détection précoce du cancer du sein
WO2010009337A3 (fr) Signatures et déterminants de la pc associés au cancer de la prostate et leurs procédés d’utilisation
WO2009158620A3 (fr) Signatures et déterminants associés à des métastases, et leurs procédés d'utilisation
WO2012047618A3 (fr) Biomarqueurs de mésothéliome et utilisations de ceux-ci
WO2011106709A3 (fr) Biomarqueurs épithéliaux pour pronostiquer un cancer
EP3064940A4 (fr) Marqueur biologique salivaire pour le cancer, procédé et dispositif pour le tester et procédé de détermination d'un marqueur biologique salivaire pour le cancer
HK1214652A1 (zh) 用於检测胰腺癌的方法和组合物
EP4461824A3 (fr) Kit ou dispositif de détection du cancer du tractus biliaire, et procédé de détection
EP3967769A3 (fr) Kit ou dispositif de détection du cancer du poumon et procédé de détection
WO2009037572A3 (fr) Combinaisons de bio-marqueurs du cancer colorectal
EP3971299A3 (fr) Nécessaire ou dispositif de détection du cancer colorectal et méthode de détection associée
WO2013066369A3 (fr) Procédés de détection de maladie du greffon contre l'hôte
WO2012048113A3 (fr) Biomarqueurs de cancer
WO2013022786A3 (fr) Biomarqueurs micro-arn
EP3800253A3 (fr) Kit ou dispositif de détection du cancer de la prostate et procédé de détection
NZ629555A (en) Monocyte biomarkers for cancer detection
EP3054298A4 (fr) Procédé de détection d'une tumeur pancréatique, anticorps, et kit de détection de tumeur pancréatique
WO2012075069A3 (fr) Signatures et déterminants associés au cancer et leurs méthodes d'utilisation
WO2014172390A3 (fr) Méthodes de détection de métastases cancéreuses
WO2013025322A3 (fr) Score de risque de pronostic à base d'un marqueur dans le cancer du foie
WO2013044187A3 (fr) Détection du cancer de l'ovaire
GB2496557A (en) Products and methods for identifying rock samples
WO2012135749A3 (fr) Marqueurs biologiques pour prévoir la sensibilité à des traitements du cancer
WO2013181576A3 (fr) Méthodes d'évaluation et de fabrication de produits biologiques

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12762938

Country of ref document: EP

Kind code of ref document: A2